Marshall Wace North America’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $4.63M | Buy |
+543,582
| New | +$4.63M | 0.02% | 525 |
|
|
2021
Q2 | – | Sell |
-503,860
| Closed | -$11.1M | – | 1848 |
|
|
2021
Q1 | $11.1M | Sell |
503,860
-479,007
| -49% | -$10.6M | 0.05% | 371 |
|
|
2020
Q4 | $30.4M | Buy |
982,867
+450,366
| +85% | +$13.9M | 0.14% | 179 |
|
|
2020
Q3 | $10.8M | Buy |
+532,501
| New | +$10.8M | 0.07% | 270 |
|